Davenport & Co LLC
- SEC CIK
- 0000887777
- Latest filing
- Jul 13, 2026
EVFM holding history
Evofem Biosciences, Inc. in every 13F filed by Davenport & Co LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
EVFM overviewAll 13F holders of EVFMFull Q2 2026 holdings
- Shares (Q2 2022)
- 0
- Sold out in Q2 2022
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2022 | 0 | $0 | 0.0% | −39,500−100.0% | Sold out | Holders |
| Q1 2022 | 39,500 | $13.0K | <0.1% | −26,500−40.2% | Reduced | Holders |
| Q4 2021 | 66,000 | $25.0K | <0.1% | −304,748−82.2% | Reduced | Holders |
| Q3 2021 | 370,748 | $274.0K | <0.1% | −30,852−7.7% | Reduced | Holders |
| Q2 2021 | 401,600 | $454.0K | <0.1% | +2,300+0.6% | Added | Holders |
| Q1 2021 | 399,300 | $699.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.